Martine F. Roussel

St. Jude Children's Research Hospital — United States

Medicine · Health Sciences

96h-index37.7kcitations650works1.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer-related Molecular Pathways(113), Glioma Diagnosis and Treatment(94), CAR-T cell therapy research(80), Epigenetics and DNA Methylation(62), Hedgehog Signaling Pathway Studies(62)

Publications647 total

Targeting the p53 pathway to treat atypical teratoid rhabdoid tumors
Neuro-Oncology Pediatrics·2025Open Access
Supplementary Table S1 from Combination of Ribociclib with BET-Bromodomain and PI3K/mTOR Inhibitors for Medulloblastoma Treatment <i>In Vitro</i> and <i>In Vivo</i>
2025Open Access
Supplementary Table S4 from Combination of Ribociclib with BET-Bromodomain and PI3K/mTOR Inhibitors for Medulloblastoma Treatment <i>In Vitro</i> and <i>In Vivo</i>
2025Open Access
Supplementary Table S2 from Combination of Ribociclib with BET-Bromodomain and PI3K/mTOR Inhibitors for Medulloblastoma Treatment <i>In Vitro</i> and <i>In Vivo</i>
2025Open Access
Supplementary Methods, Figures and Tables from Combination of Ribociclib with BET-Bromodomain and PI3K/mTOR Inhibitors for Medulloblastoma Treatment <i>In Vitro</i> and <i>In Vivo</i>
2025Open Access
Hidden-driver inference reveals synergistic brain-penetrant therapies for medulloblastoma
2025Open Access
EPCO-59. INTEGRATED MULTI-OMIC PROFILING REVEALS PROTEOMIC HETEROGENEITY AND PATHWAY DYNAMICS IN MEDULLOBLASTOMA
Neuro-Oncology·2025Open Access
EXTH-34. Increased capacity for expansion, not persistence, improves preclinical B7-H3 targeted CAR T cell therapy against aggressive Group 3 medulloblastomas
Neuro-Oncology·2025Open Access
EXTH-20. Genetic modeling of ELP1-associated Sonic hedgehog medulloblastoma identifies MDM2 as a selective therapeutic target
Neuro-Oncology·2025
296 Improving CAR T-cell therapy for group 3 medulloblastoma via targeted tumor microenvironment reprogramming and blood-brain barrier permeability enhancement
Regular and Young Investigator Award Abstracts·2025Open Access
EXTH-71. Optimizing CAR T-Cell therapy in group 3 medulloblastoma through tumor microenvironment modulation and blood-brain barrier disruption
Neuro-Oncology·2025Open Access
CTP-06. Molecular insights into response and resistance in children with relapsed/refractory brain tumors on ribociclib combination therapy: results from SJDAWN
Neuro-Oncology·2025Open Access
Abstract A038: Overcoming myeloid-mediated immunosuppression and enhancing blood-brain barrier access to advance B7H3 CAR T cell therapy in high-risk Medulloblastoma
Cancer Research·2025
Recommendations of the jury of the consensus conference on the interpretation and communication of neuropsychology scores (Paris, November 22, 2024)
Revue de neuropsychologie·2025Open Access
The interpretation and communication neuropsychological test scores: Putting an end to the Tower of Babel
Revue de neuropsychologie·2025Open Access
Melanoma antigens in pediatric medulloblastoma contribute to tumor heterogeneity and species-specificity of group 3 tumors
Acta Neuropathologica Communications·2025· 1 citedOpen Access
Genetic modeling of ELP1-associated Sonic hedgehog medulloblastoma identifies MDM2 as a selective therapeutic target
Cancer Cell·2025· 1 citedOpen Access
Abstract LB175: Identification of therapeutic targets in high-risk SHH medulloblastoma
Cancer Research·2025
Abstract 6379: Identification of selective, orally bioavailable aurora A degraders for treatment of pediatric and adult cancers
Cancer Research·2025
Developmental Origins and Oncogenesis in Medulloblastoma
Annual Review of Neuroscience·2025· 2 citedOpen Access
page 1 of 33Next →

Frequent Co-authors

Charles J. Sherr(22), Frédérique Zindy(10), David W. Ellison(6), Richard J. Gilbertson(6), James R. Downing(5), Richard A. Ashmun(5), Jason D. Weber(5), Daisuke Kawauchi(5), Carl W. Rettenmier(4), Christine M. Eischen(4), John L. Cleveland(4), Stanley Pounds(4), David Finkelstein(4), Amar Gajjar(4), Takehiko Kamijo(3), Dawn E. Quelle(3), C J Sherr(3), Jun‐ya Kato(3), Andrey Korshunov(3), David Jones(3)